Stephen Abreu has been appointed by the Board as Executive Director. He will lead the organization's overall strategy and ...

Opuviz, which references Regeneron Pharmacueticals’ vision loss inhibitor Eylea, treats wet age-related macular degeneration, ...

Biogen and UCB on Tuesday shared an expanded dataset for their Phase 3 lupus program, which they said two months ago ...

UCB and Biogen (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, or DZP, a novel Fc-free anti-CD40L drug candidate, demonstrating significant ...

(RTTNews) - UCB and Biogen Inc. (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, a Fc-free anti-CD40L drug candidate, showing significant clinical ...

The department will ask the judge to require measures related to artificial intelligence and its Android smartphone operating system, according to people familiar with the plans.

Biogen had planned to sell the drug for $56,000 for a year ... When there is so much money on the table, people will cheat, just as they are willing to break the law to sell fentanyl and other illegal ...

“We now need Biogen, the pharmaceutical company that manufactures Tofersen, to come back to the table and get the application ...

The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar referencing Eylea (aflibercept). The biosimilar has been developed and registered by ...

The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar ...